Lensar (LNSR) Interest Coverage Ratio (2019 - 2020)
Lensar (LNSR) reported Interest Coverage Ratio of 72.49 for Q3 2020, down 571.0% year-over-year from 15.39 in Q4 2019, and down 1165.74% quarter-over-quarter from 5.73 in Q2 2020.
Lensar (LNSR) Interest Coverage Ratio (2019 - 2020) Analysis & Trends
Lensar (LNSR) has 2 years of Interest Coverage Ratio data on file, last reported at 72.49 in Q3 2020.
- Interest Coverage Ratio for Q3 2020 came in at 72.49, down 571.0% year-over-year; the trailing twelve-month figure through Jun 2021 was 325.15 (down 5215.5% YoY), and the FY2020 annual result was 13.81, down 117.31% from the prior year.
- Interest Coverage Ratio eased to 72.49 in Q3 2020 per LNSR's latest filing, from 5.73 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 3.49 in Q4 2019 and troughed at 72.49 in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 7.73 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 8.09 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 12.23 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -2.90 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 5.36 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 20.98 |
| 10 | Lensar | 70.05 Mn | 70.34 Mn | 6.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -72.49 |
| Jun 30, 2020 | -5.73 |
| Mar 31, 2020 | -5.13 |
| Dec 31, 2019 | -3.49 |
| Sep 30, 2019 | -10.80 |